Ipca Laboratories rebounds 5.9% from exit level

IPCALAB Ipca Laboratories Limited closed 5 November 5.9 percent above the 16 October close that triggered my exit. The board was due to consider Q2 FY27 results on 5 November, and I found no outcome in the sources I could reach. Last reported quarter, Q1 FY27 (consolidated): Revenue: Rs 2,788.10 crore, up 20.8% YoY from Rs 2,308.85 crore EBITDA: Rs 637.94 crore; margin 22.9%, against 18.4% a year earlier PAT: Rs 401.89 crore, up 72.3% YoY, attributable to owners My 17 October post recorded the exit on a close below Rs 1,880. A rebound alone is not a re-entry, and I found no company event behind this one. Ipca Laboratories [IPCALAB][***** closed at Rs 1,916.91 on 5 November on StockGro (NSE Rs 1,949.60 at 3:51 PM), 5.2 percent below its 52-week high of Rs 2,021.97. P/E 34.7; sector P/E near 45. My view: stay out until the Q2 print. The exit still stands; a rebound does not reverse it. The exchange print is above the Rs 1,889 to 1,920 zone I named on 8 October, while StockGro’s close sits inside it, so the signal is not clean. Re-entry needs three things at once: Q2 revenue growth near 12 percent or better, an EBITDA margin near 23 percent, and a close back above Rs 1,889 on the NSE. Any re-entry fails on a close below Rs 1,880. What would change my mind: a Q2 print that meets both growth and margin markers, or a named company event behind the 16 October fall, which I did not find. Next trigger: Q2 FY27 results, board date 5 November per the exchange intimation; outcome not yet sourced. Disclosure: Vijay Kumar Gupta, SEBI Registered Research Analyst, INH000020226, Vijay Gupta Advisory. SEBI registration and NISM certification do not guarantee performance or assure returns. Securities markets are subject to market risks. No holdings in the subject company.